Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease

Langenbecks Arch Surg. 2008 Sep;393(5):639-45. doi: 10.1007/s00423-008-0384-5. Epub 2008 Jul 24.

Abstract

Purpose: Usefulness of rapid intraoperative parathyroid hormone assay (RI-PTH) for diagnosis of multiglandular disease during parathyroidectomy is still debated.

Materials and methods: Two hundred seven patients were selected for focused parathyroidectomy for a suspicious single adenoma. RI-PTH results were interpreted on the basis of our criteria for prediction of multiglandular disease (a < 50% drop from the highest pre-excision level and/or a T20 concentration higher than reference range and/or >7.5 ng/L higher than the T10). The results of these criteria were compared with the Miami Criterion (MC).

Results: One hundred ninety-seven uniglandular disease and ten multiglandular disease were found. Our criteria identified all but one patient with multiglandular disease (false positive (FP) rate 0.5%; specificity 90%). On the basis of MC, RI-PTH monitoring would have resulted in five FP results, with a specificity of 50%.

Conclusions: Despite the higher rate of unnecessary bilateral exploration, our criteria results in a lower FP, markedly reducing the risk of missing multiglandular disease.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Intraoperative Complications / blood*
  • Intraoperative Complications / diagnosis
  • Male
  • Middle Aged
  • Monitoring, Intraoperative*
  • Neoplasm, Residual / blood
  • Neoplasm, Residual / diagnosis
  • Neoplasm, Residual / surgery*
  • Neoplasms, Multiple Primary / blood
  • Neoplasms, Multiple Primary / diagnosis
  • Neoplasms, Multiple Primary / surgery*
  • Parathyroid Hormone / blood*
  • Parathyroid Neoplasms / blood
  • Parathyroid Neoplasms / diagnosis
  • Parathyroid Neoplasms / surgery*
  • Parathyroidectomy*
  • Predictive Value of Tests
  • Reoperation
  • Unnecessary Procedures
  • Video-Assisted Surgery
  • Young Adult

Substances

  • Parathyroid Hormone